{"id":"NCT03715465","sponsor":"University of Michigan","briefTitle":"The Clinical Utility of Measuring the Circadian Clock in Treatment of Delayed Sleep-Wake Phase Disorder","officialTitle":"The Clinical Utility of DLMO in the Treatment of Delayed Sleep-Wake Phase Disorder: A Randomized Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-02-15","primaryCompletion":"2021-11-05","completion":"2021-11-05","firstPosted":"2018-10-23","resultsPosted":"2022-11-25","lastUpdate":"2022-11-25"},"enrollment":44,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Delayed Sleep Phase Syndrome"],"interventions":[{"type":"DRUG","name":"Melatonin 0.5 MG","otherNames":[]},{"type":"OTHER","name":"Dim Light Melatonin Onset (salivary)","otherNames":[]}],"arms":[{"label":"Estimated DLMO","type":"ACTIVE_COMPARATOR"},{"label":"Measured DLMO","type":"EXPERIMENTAL"}],"summary":"This study will test whether measuring the circadian clock during treatment of delayed sleep-wake phase disorder results in greater improvements in sleep compared to estimating the circadian clock.","primaryOutcome":{"measure":"Change From Baseline Time of Dim Light Melatonin Onset (DLMO) at 4 Weeks","timeFrame":"After 4 weeks of melatonin therapy","effectByArm":[{"arm":"Measured DLMO","deltaMin":-1.23,"sd":1.53},{"arm":"Estimated DLMO","deltaMin":-1.58,"sd":1.3}],"pValues":[{"comp":"OG000 vs OG001","p":"0.510"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":9},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["38445651"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":20},"commonTop":["Somnolence","Headaches","Insomnia","Decreased appetite","Anxiety"]}}